The cell biology of CTL killing
β Scribed by Gillian M. Griffiths
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 524 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0952-7915
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Dendritic cells (DCs) can acquire antigen(s) from apoptotic tumor cells, resulting in an immunogen that can induce class I-restricted cytotoxic T lymphocytes (CTLs) and protective tumor rejection. Here, we investigated whether DCs derived from ascitic monocytes of patients with ovarian carcinoma cou
p53 is upregulated in the majority of spontaneous tumors and the HLA class I molecule HLA-A2 is expressed by approximately 50% of the caucasians. Potentially, these facts make HLA-A2-binding p53 peptides for CTL-inducing immunotherapy applicable to a broad range of cancer patients. In our study, we